- Home
- NUS vs REFI Comparison
NUS vs REFI Comparison
Compare NUS & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- REFI
- Stock Information
- Founded
- NUS 1984
- REFI 2021
- Country
- NUS United States
- REFI United States
- Employees
- NUS N/A
- REFI N/A
- Industry
- NUS Other Pharmaceuticals
- REFI Real Estate Investment Trusts
- Sector
- NUS Health Care
- REFI Real Estate
- Exchange
- NUS Nasdaq
- REFI Nasdaq
- Market Cap
- NUS 308.1M
- REFI 291.9M
- IPO Year
- NUS 1996
- REFI 2021
- Fundamental
- Price
- NUS $6.15
- REFI $14.85
- Analyst Decision
- NUS Hold
- REFI Strong Buy
- Analyst Count
- NUS 2
- REFI 3
- Target Price
- NUS $6.88
- REFI $20.00
- AVG Volume (30 Days)
- NUS 626.1K
- REFI 112.2K
- Earning Date
- NUS 05-08-2025
- REFI 05-07-2025
- Dividend Yield
- NUS 3.90%
- REFI 13.87%
- EPS Growth
- NUS N/A
- REFI N/A
- EPS
- NUS N/A
- REFI 1.88
- Revenue
- NUS $1,732,084,000.00
- REFI $56,790,054.00
- Revenue This Year
- NUS N/A
- REFI $17.87
- Revenue Next Year
- NUS N/A
- REFI N/A
- P/E Ratio
- NUS N/A
- REFI $7.90
- Revenue Growth
- NUS N/A
- REFI 4.68
- 52 Week Low
- NUS $5.32
- REFI $12.76
- 52 Week High
- NUS $14.00
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- NUS 49.12
- REFI 59.49
- Support Level
- NUS $5.63
- REFI $14.50
- Resistance Level
- NUS $6.36
- REFI $14.81
- Average True Range (ATR)
- NUS 0.27
- REFI 0.27
- MACD
- NUS 0.08
- REFI 0.12
- Stochastic Oscillator
- NUS 79.81
- REFI 93.44
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.